NCT00208169View on ClinicalTrials.gov

Abilify Therapy for Reducing Comorbid Substance Abuse

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

June 30, 2007

Conditions
SchizophreniaSchizoaffective DisorderBipolar DisorderMajor Depressive DisorderAnxiety DisordersSubstance Abuse
Interventions
DRUG

Aripiprazole

Trial Locations (1)

68131

Creighton University Psychiatry and Research Center, Omaha

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Creighton University

OTHER